- International Partnership Results in New Vaccine for Cattle in Africa
A vaccine against contagious bovine pleuropneumonia has been licensed for commercial production by the Kenya Veterinary Vaccines Production Institute.
- 'A few infected people can really impact what goes on locally'
Saskatoon scientist thrilled to be developing Middle East Respiratory Syndrome vaccine for use on camels.
- Saskatoon researcher Dr. Andrew Potter honoured with lifetime achievement award
Renowned worldwide, Dr. Potter has received an award for a career’s worth of cutting-edge discoveries.
- Dr. Andrew Potter receives SHRF Achievement Award
Dr. Potter and Dr. Karniychuk were winners at the 2017 Saskatchewan Health Research Foundation Santé Awards.
- The search continues for TB and JD vaccines
"We could be lucky and find our vaccine candidates for bovine tuberculosis and Johne’s disease within a month, or it could take a year and a half. We hope within a two-year window we will have candidates ready to test out in the field.”
- VIDO-InterVac releases 2016-2017 Annual Report
Through another year, VIDO-InterVac continued to build its reputation as one of Canada’s premier research institutions in the fields of human and animal health, focusing on vaccine and technology development.
- Going viral
Maybe it starts with a mild fever, a scratch at the back of your throat or a cough you just can’t shake. Nothing a few days of bed rest won’t fix, hopefully. (University of Saskatchewan, On Campus News)
- Tackling infectious diseases: Canada’s role in the global effort
Every year infectious diseases emerge that threaten the health of people and animals, and impact the global economy. (Biotechnology Focus)
- VIDO-InterVac to field test a bovine TB prototype vaccine in 2 years
Researchers at VIDO-InterVac are working on a vaccine for bovine tuberculosis. An outbreak of the disease last fall has had a devastating effect on some Saskatchewan farmers. (CBC News Saskatoon)
- VIDO-InterVac helping to fight Zika virus
VIDO-InterVac—the first place in the world to develop a swine model for the study of Zika virus infection—has secured $700,000 for research to investigate how the virus causes disease and to test new drugs and vaccines.